Kawahara, Takuya http://orcid.org/0000-0002-3859-2756
Iwamoto, Takayuki
Takashima, Ikumi
Hanazawa, Ryoichi
Uemura, Kohei
Uemura, Yukari
Mukai, Hirofumi
Kikawa, Yuichiro
Taira, Naruto
Funding for this research was provided by:
Public Health Research Foundation
Article History
Received: 11 April 2022
Accepted: 12 July 2022
First Online: 20 July 2022
Declarations
:
: The study was approved by the independent ethics committee at each study site and was conducted in agreement with the Helsinki Declaration, ethical guidelines for medical research on humans, and ethics guidelines for human genome/gene analysis research.
: Informed consent was obtained from all individual participants included in the study.
: Dr. Mukai received honoraria from Pfizer, Takeda, Daiichi Sankyo, and Taiho, and research grant from Japanese government, Daiichi Sankyo, and Pfizer, outside the submitted work. Dr. Mukai is a member of the Board of Directors of Japan Breast Cancer Society. Dr. Kikawa has received honoraria from Eisai, Novartis, Pfizer, Lilly, Taiho, and Chugai, outside the submitted work.